Yifeng Bai

Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer

Xiaoshan Wang, Yifeng Bai, Vivek Verma et al. · JNCI Journal of the National Cancer Institute · 2022 · 255 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7

Yanqin Sun, Yifeng Bai, Fan Zhang et al. · Biochemical and Biophysical Research Communications · 2009 · 181 citations

Medicine, Cancer Biology, Oncology +14

Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis

Linlang Guo, Yongguang Liu, Yifeng Bai et al. · European Journal of Cancer · 2010 · 150 citations

Life Sciences, Molecular Biology, Oncology +14

Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100

Fa-Man Xiao, Yifeng Bai, Zhenzhu Chen et al. · European Journal of Cancer · 2014 · 136 citations

Life Sciences, Genetics, Oncology +8

MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2

Hongzhan Liao, Yifeng Bai, Shengcong Qiu et al. · Oncotarget · 2015 · 116 citations · Full text

Medicine, Neurosurgery, Oncology +17